SCHEMBL7937100

SCHEMBL7937100

COc1ccccc1N(NC(=O)[C@H](CC(C)C)[C@H](CC=Cc1ccccc1)C(=O)NOC1CCCCO1)S(C)(=O)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 1/20 0.48
P2RX3 P56373 1/20 0.33
ITGB1 P05556 1/20 0.32
ITGA4 P13612 1/20 0.32
CTSD P07339 1/20 0.32
BACE1 P56817 1/20 0.32
BACE2 Q9Y5Z0 1/20 0.32
TSHR P16473 2/20 0.32
USP2 O75604 1/20 0.32
CTSK P43235 1/20 0.31
MMP2 P08253 2/20 0.30
MMP9 P14780 2/20 0.30
ANPEP P15144 2/20 0.30
LTA4H P09960 1/20 0.30
LAP3 P28838 1/20 0.30
NPEPPS P55786 1/20 0.30
ERAP2 Q6P179 1/20 0.30
ERAP1 Q9NZ08 1/20 0.30
GRIK1 P39086 1/20 0.30
GRIK2 Q13002 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6942217 0.92 ADAM17 (0.49) ADAM17P2RX3TGFBR1
SCHEMBL6945855 0.90 ADAM17 (0.48) ADAM17P2RX3TGFBR1
SCHEMBL6947352 0.90 ADAM17 (0.51) ADAM17P2RX3MMP2MMP9ANPEP
SCHEMBL6940024 0.89 ADAM17 (0.48) ADAM17CTSDBACE1BACE2TSHR
SCHEMBL6943197 0.89 ADAM17 (0.46) ADAM17P2RX3
SCHEMBL6945960 0.87 ADAM17 (0.51) ADAM17P2RX3MMP2MMP9ANPEP
SCHEMBL6937788 0.87 ADAM17 (0.51) ADAM17P2RX3MMP2MMP9ANPEP
SCHEMBL6943375 0.87 ADAM17 (0.53) ADAM17P2RX3MMP2MMP9ANPEP
SCHEMBL6946888 0.87 ADAM17 (0.48) ADAM17P2RX3CTSKMMP2MMP9
SCHEMBL6947109 0.86 ADAM17 (0.57) ADAM17P2RX3CTSKMMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235787-B1 ANTIINFLAMMATORY AGENTS; RHEUMATIC DISEASES; BONE DISORDERS; SKIN DISORDERS; MULTIPLE SCLEROSIS HOFFMANN-LA ROCHE INC. 2001-05-22 US disclosed